|
1
|
Luo J, Chia KS, Chia SE, et al: Secular
trends of nasopharyngeal carcinoma incidence in Singapore, Hong
Kong and Los Angeles Chinese populations, 1973–1997. Eur J
Epidemiol. 22:513–521. 2007.PubMed/NCBI
|
|
2
|
Jia WH, Huang QH, Liao J, et al: Trends in
incidence and mortality of nasopharyngeal carcinoma over a 20–25
year period (1978/1983–2002) in Sihui and Cangwu counties in
southern China. BMC Cancer. 6:1782006.PubMed/NCBI
|
|
3
|
Sham JS, Choy D and Wei WI: Nasopharyngeal
carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys.
19:929–933. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ho FC, Tham IW, Earnest A, et al: Patterns
of regional lymph node metastasis of nasopharyngeal carcinoma: a
meta-analysis of clinical evidence. BMC Cancer. 12:982012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yi JL, Gao L, Huang XD, et al:
Nasopharyngeal carcinoma treated by radical radiotherapy alone:
ten-year experience of a single institution. Int J Radiat Oncol
Biol Phys. 65:161–168. 2006.
|
|
6
|
Sham JS and Choy D: Breast metastasis from
nasopharyngeal carcinoma. Eur J Surg Oncol. 17:91–93. 1991.
|
|
7
|
Yeh CN, Lin CH and Chen MF: Clinical and
ultrasonographic characteristics of breast metastases from
extramammary malignancies. Am Surg. 70:287–290. 2004.PubMed/NCBI
|
|
8
|
Driss M, Abid L, Mrad K, et al: Breast
metastases from undifferentiated nasopharyngeal carcinoma.
Pathologica. 99:428–430. 2007.PubMed/NCBI
|
|
9
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. 7th edition. Lippincott-Raven; Philadelphia,
PA, USA: 2009
|
|
10
|
Al-Sarraf M, LeBlanc M, Giri PG, et al:
Chemoradiotherapy versus radiotherapy in patients with advanced
nasopharyngeal cancer: phase III randomized intergroup study 0099.
J Clin Oncol. 16:1310–1317. 1998.
|
|
11
|
Chen L, Hu CS, Chen XZ, et al: Concurrent
chemoradiotherapy plus adjuvant chemotherapy versus concurrent
chemoradiotherapy alone in patients with locoregionally advanced
nasopharyngeal carcinoma: a phase 3 multicentre randomised
controlled trial. Lancet Oncol. 13:163–171. 2012. View Article : Google Scholar
|
|
12
|
Ng WT, Lee MC, Hung WM, et al: Clinical
outcomes and patterns of failure after intensity-modulated
radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol
Phys. 79:420–428. 2011. View Article : Google Scholar
|
|
13
|
Domanski HA: Metastases to the breast from
extramammary neoplasms. Acta Cytol. 40:1293–1300. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li YH, Wang FH, Jiang WQ, et al: Phase II
study of capecitabine and cisplatin combination as first-line
chemotherapy in Chinese patients with metastatic nasopharyngeal
carcinoma. Cancer Chemother Pharmacol. 62:539–544. 2008. View Article : Google Scholar
|
|
15
|
Chen C, Wang FH, Wang ZQ, et al: Salvage
gemcitabine-vinorelbine chemotherapy in patients with metastatic
nasopharyngeal carcinoma pretreated with platinum-based
chemotherapy. Oral Oncol. 48:1146–1151. 2012. View Article : Google Scholar
|
|
16
|
You B, Le Tourneau C, Chen EX, et al: A
Phase II trial of erlotinib as maintenance treatment after
gemcitabine plus platinum-based chemotherapy in patients with
recurrent and/or metastatic nasopharyngeal carcinoma. Am J Clin
Oncol. 35:255–260. 2012. View Article : Google Scholar
|
